ERBB2 and breast cancer: Importantly, BC is molecularly classified into four subtypes according to hormone receptor expression and the Ki-67 index into luminal-like (A and B), normal-like, HER-2 enriched and basal-like (triple negative breast cancer, TNBC) carcinomas.